Android app on Google Play

Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 23c

July 19, 2012 4:07 PM EDT Send to a Friend
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.68, $0.23 better than the analyst estimate of $0.45. Revenue for the quarter came in at $230.6 million versus the consensus estimate of $226.05 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.




You May Also Be Interested In


Related Categories

Earnings, Hot Earnings

Related Entities

Earnings

Add Your Comment